About the Trial
A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) - STABLe-mates Trial.
The primary objective of this study is to test the hypothesis that the 3-year overall survival in high risk operable patients with Stage I NSCLC is greater in patient who undergo SAbR as compared to standard sublobar resection (SR).
Please review slides for this study. Training records are required prior to study activation at your site. Please contact Sarah Hardee at Sarah.Hardee@utsouthwestern.edu for more information about completing this requirement for study teams.
Protocol version 5 presentation for participating institutions